Introduction
============

The objective of this study was to determine the efficacy and safety of subcutaneous (s.c.) once-daily (OD) glargine insulin, a long-acting insulin, in comparison with a s.c. regular insulin, based on a protocolized sliding scale regimen for achieving glycemic control in patients admitted to the ICU.

Methods
=======

One hundred patients admitted to the ICU with an admission capillary blood glucose (CBG) \>150 mg/dl (8.3 mmol/l) were involved in this prospective, randomized study. Patients with age \<18 years, pregnancy, shock, requiring continuous intravenous insulin infusion, renal failure were excluded. Patients were randomly assigned to receive either s.c. glargine insulin 10 U (CBG ≤ 9.9 mmol/l) or 18 U (CBG ≥ 10.1 mmol/l) s.c. OD (Group G, *n*= 50), or s.c. regular insulin based on a 6-hourly sliding scale (Group R, *n*= 50). CBGs were recorded at 6-hour intervals up to 96 hours or until ICU discharge, whichever was earlier. The target CBG in both groups was \<150 mg/dl (8.3 mmol/l). Patients in group G received rescue doses of regular insulin, as required. Demographic characteristics, mean and median CBG, and episodes of hypoglycemia were studied.

Results
=======

Demographic profiles were comparable between the two groups. There was no significant difference in mean CBG in both groups (Group G 152.1 mg/dl (8.4 mmol/l), Group R 149.9 mg/dl (8.3 mmol/l), *P*= 0.66). Median CBGs were comparable at 6-hourly time points in both the groups except at 0 and 6 hours in the glargine arm (CBG at 0 and 6 hours, Group G 10.0 mmol/l and 9.9 mmol/l, Group R 9.4 mmol/l and 8.3 mmol/l, *P*= 0.04 and 0.02, respectively) (Figure [1](#F1){ref-type="fig"}). There were three episodes of hypoglycemia in Group G and one in Group R, which were corrected.
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Conclusion
==========

OD s.c. glargine insulin is a safe and effective alternative to regular insulin for glycemic control in critically ill patients.
